To Assess Ear Blood Flow During Dialysis

Status Recruiting

Clinical Trial Summary

This is a prospective observational pilot study of patients under the care of the Royal Free Hospital with chronic kidney disease who have been established on regular thrice weekly haemodialysis treatments in a dialysis centre,to measure the changes in blood flow in the ear during haemodialysis.

Clinical Trial Description

10 patients, attending for thrice weekly outpatient haemodiafiltration shall be studied during a dialysis session using a CE marked commercially available digital otoscope capable of recording digital videos of the tympanic membrane and ear canal. Patients will receive standard clinical care and monitoring of their dialysis session, which includes recording of blood pressure and changes in haematocrit and volume status during dialysis and noting patient symptoms. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT02545920
Study type	Observational
Source	University College, London
Contact	vashist deelchand
Phone	02077940500
Email	vashist.deelchand@nhs.net
Status	Recruiting
Phase
Start date	September 2015
Completion date	August 30, 2021

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT04510090` - Evaluate the Safety, Tolerability, and PK of EP547 in Healthy Subjects and Subjects With Cholestatic or Uremic Pruritus	Phase 1
Completed	`NCT02546037` - Clotting With Different Dialyzer Membranes
Completed	`NCT02134314` - C1INH Inhibitor Preoperative and Post Kidney Transplant to Prevent DGF & IRI	Phase 1/Phase 2
Recruiting	`NCT01912001` - Virtual Ward for Home Dialysis	N/A
Completed	`NCT00986947` - Desensitization of Highly Sensitized Deceased Donor Renal Transplantation Candidates	Phase 2
Completed	`NCT01158742` - Live Kidney Donor Study -Renal Function Study	N/A
Withdrawn	`NCT00807274` - Renal Function in Adults With Congenital Heart Disease.	N/A
Completed	`NCT00765661` - Pharmacokinetics of LCP-Tacro(TM) Once Daily And Prograf® Twice A Day in Adult De Novo Kidney Transplant Patients	Phase 2
Completed	`NCT00369382` - Study Of The Safety And Efficacy Of Conversion From A CNI To Sirolimus In Renally-Impaired Heart Transplant Recipients	Phase 4
Completed	`NCT00183248` - Using Donor Stem Cells and Alemtuzumab to Prevent Organ Rejection in Kidney Transplant Patients	Phase 1/Phase 2
Enrolling by invitation	`NCT05324878` - Honoring Individual Goals and Hopes: Implementing Advance Care Planning for Persons With Kidney Disease on Dialysis
Completed	`NCT05272800` - BIS-guided Fluid Management in HD Patients	N/A
Completed	`NCT03836508` - Effect of Dialysis Membranes on Inflammatory and Immune Processes in Hemodialysis	N/A
Completed	`NCT01756508` - Eculizumab for Prevention and Treatment of Kidney Graft Reperfusion Injury	Phase 2
Completed	`NCT03723668` - Kidney Transplant Outcome and Organ Acceptance Practice Pattern: A Nationwide Analyses in the US and France
Recruiting	`NCT04277377` - Nanoparticle for DSA Removal
Terminated	`NCT00450333` - Dynepo Infrequent Dosing Study	Phase 3
Terminated	`NCT03840343` - Patient-Derived Stem Cell Therapy for Diabetic Kidney Disease	Phase 1
Recruiting	`NCT04714853` - Different Dialysis Modalities and Diet on Gastrointestinal Biome and Azotaemic Toxins
Completed	`NCT02785445` - Healthy.io Method Comparison & User Performance Study	N/A